Literature DB >> 27466789

Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.

Clifton D Fuller1, Abdallah S R Mohamed1,2, Adam S Garden1, G Brandon Gunn1, Collin F Mulcahy1, Mark Zafereo3, Jack Phan1, Stephen Y Lai3, Jan S Lewin3, Katherine A Hutcheson3, Steven J Frank1, Beth M Beadle1, William H Morrison1, Adel K El-Naggar4, Esengul Kocak-Uzel1,5, Lawrence E Ginsberg6, Merril S Kies7, Randal S Weber3, David I Rosenthal1.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the long-term outcomes after initial definitive or adjuvant radiotherapy (RT) for T3 laryngeal cancers.
METHODS: We reviewed 412 patients treated for T3 laryngeal squamous cell cancer from 1985 to 2011.
RESULTS: The 10-year overall survival (OS) was 35%; disease-specific-survival (DSS) was 61%; locoregional control was 76%; and freedom from distant metastasis was 83%. Chemotherapy, age, performance status <2, node-negative status, and glottic subsite were associated with improved survival (all p < .03). Larynx preservation with induction and/or concurrent chemoradiotherapy (LP-CRT) had better laryngectomy-free survival than RT alone (LP-RT; hazard ratio [HR] = 0.62; 95% confidence interval [CI] = 0.47-0.81; p = .0005); 10-year laryngectomy-free survival rates of the LP-CRT cohort (37%) were higher than those of the LP-RT cohort (18%). The 5-year DSS and OS rates of the LP-CRT cohort (79% and 67%) were better after total laryngectomy with postoperative RT (TL-PORT; 61% and 50%) and LP-RT (64% and 46%; p < .006 for all).
CONCLUSION: In patients with T3 laryngeal cancers, LP-CRT provides better functional, oncologic, and survival outcomes than historical TL-PORT or LP-RT does.
© 2016 Wiley Periodicals, Inc. Head Neck 38: 1739-1751, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  T3; outcomes; radiotherapy; survival; total laryngectomy

Mesh:

Year:  2016        PMID: 27466789      PMCID: PMC5539952          DOI: 10.1002/hed.24532

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  23 in total

1.  Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers.

Authors:  W S MACCOMB; G H FLETCHER
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1957-03

2.  Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.

Authors:  Henry T Hoffman; Kimberly Porter; Lucy H Karnell; Jay S Cooper; Randall S Weber; Corey J Langer; Kie-Kian Ang; Greer Gay; Andrew Stewart; Robert A Robinson
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

3.  Survival outcomes in advanced laryngeal cancer.

Authors:  Uchechukwu C Megwalu; Andrew G Sikora
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2014-09       Impact factor: 6.223

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Changes in treatment of advanced laryngeal cancer 1985-2001.

Authors:  Amy Y Chen; Nicole Schrag; Yongping Hao; W Dana Flanders; James Kepner; Andrew Stewart; Elizabeth Ward
Journal:  Otolaryngol Head Neck Surg       Date:  2006-12       Impact factor: 3.497

6.  Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.

Authors:  Abrahim Al-Mamgani; Peter Van Rooij; Lisa Tans; David N Teguh; Peter C Levendag
Journal:  Technol Cancer Res Treat       Date:  2012-10-19

7.  The evaluation of treatment of patients with extensive squamous cancer of the vocal cords.

Authors:  R H Jesse
Journal:  Laryngoscope       Date:  1975-09       Impact factor: 3.325

Review 8.  T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results.

Authors:  C H Terhaard; G J Hordijk; P van den Broek; P C de Jong; G B Snow; F J Hilgers; B A Annyas; R E Tjho-Heslinga; J M de Jong
Journal:  Clin Otolaryngol Allied Sci       Date:  1992-10

9.  Factors predictive of survival in advanced laryngeal cancer.

Authors:  Amy Y Chen; Michael Halpern
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-12

Review 10.  Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Authors:  Nam P Nguyen; Alexander Chi; Michael Betz; Fabio Almeida; Paul Vos; Rick Davis; Benjamin Slane; Misty Ceizyk; Dave Abraham; Lexie Smith-Raymond; Michelle Stevie; Siyoung Jang; Steven Gelumbauskas; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more
  7 in total

1.  Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer.

Authors:  Mona Kamal; Sweet Ping Ng; Salman A Eraj; Crosby D Rock; Brian Pham; Jay A Messer; Adam S Garden; William H Morrison; Jack Phan; Steven J Frank; Adel K El-Naggar; Jason M Johnson; Lawrence E Ginsberg; Renata Ferrarotto; Jan S Lewin; Katherine A Hutcheson; Carlos E Cardenas; Mark E Zafereo; Stephen Y Lai; Amy C Hessel; Randal S Weber; G Brandon Gunn; Clifton D Fuller; Abdallah S R Mohamed; David I Rosenthal
Journal:  Oral Oncol       Date:  2018-02-10       Impact factor: 5.337

2.  The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.

Authors:  Shi Zhou; Xing-Hu Zhang; Yuan Zhang; Ge Gong; Xiang Yang; Wen-Hui Wan
Journal:  Cancer Manag Res       Date:  2022-05-06       Impact factor: 3.602

3.  Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

Authors:  Collin F Mulcahy; Abdallah S R Mohamed; Aasheesh Kanwar; Katherine A Hutcheson; Alokananda Ghosh; David Vock; Randal S Weber; Stephen Y Lai; Gary Brandon Gunn; Mark Zafereo; William H Morrison; Renata Ferrarotto; Adam S Garden; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2018-05-13       Impact factor: 3.147

4.  Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).

Authors:  Pei Yuan Fong; Sze Huey Tan; Darren Wan Teck Lim; Eng Huat Tan; Quan Sing Ng; Kiattisa Sommat; Daniel Shao Weng Tan; Mei Kim Ang
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

5.  Organ preservation following radiation therapy and concurrent intra-arterial low dose cisplatin infusion for advanced T2 and T3 laryngeal cancer: Long-term clinical results from a pilot study.

Authors:  Takeharu Ono; Norimitsu Tanaka; Syuichi Tanoue; Yusaku Miyata; Koichiro Muraki; Chiyoko Tsuji; Etsuyo Ogo; Takeichiro Aso; Shun-Ichi Chitose; Buichiro Shin; Tatsuyuki Kakuma; Hidehiro Etoh; Chikayuki Hattori; Toshi Abe; Hirohito Umeno
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-08

6.  Influence of Preoperative Radiation Therapy on the Occurrence of Pharyngocutaneous Fistula After Total Laryngectomy.

Authors:  Masaaki Higashino; Teruhito Aihara; Tetsuya Terada; Ryo Kawata
Journal:  Cureus       Date:  2021-03-10

7.  Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?

Authors:  Hideya Yamazaki; Gen Suzuki; Satoaki Nakamura; Shigeru Hirano; Ken Yoshida; Koji Konishi; Teruki Teshima; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2018-01-01       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.